Month: January 2026

                                                                        Ress Life Investments A/SNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.com To: Nasdaq CopenhagenDate: 26 January 2026 Corporate Announcement 03/2026 Ress Life Investments A/S announces the events of the extraordinary general meeting held on 26 January 2026. At the extraordinary general meeting of Ress Life Investments A/S held on Monday 26 January 2026, the following decisions were taken:Amendment of the Company’s Articles of Association by suspending the running of notice periods for redemption in the period from 1 January 2026 to 31 December 2026 – cf. item 1 of the agenda. Amendment of the Company’s Articles of Association by removing the appointment of Resscapital AB as the Company’s Fund Manager –...

Company successfully completes genesis mint of Standard Gold Coins, marking key operational milestone NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation gold development and technology company, today announced that it has successfully completed the first minting of its genesis Standard Gold Coins (SGC), marking a significant milestone in the operational rollout of its gold-backed digital asset framework. Each SGC corresponds to one gram of fully allocated physical gold, minted only upon verified custody intake and subject to defined compliance and authorization procedures. The initial minting represents the first issuance of SGC fully backed by allocated physical gold held in professional custody, in accordance with the governance, reserve management, and...

ELPIS II top-line trial results are anticipated in the third quarter of 2026 Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II results are positive U.S. FDA has awarded laromestrocel HLHS program Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designation Laromestrocel HLHS program has the potential to address an unmet medical need with significant U.S. market opportunities Even with current standard of care surgeries, only 50% of infants survive to adolescence due to right ventricular failureMIAMI, Jan. 26, 2026 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that...

FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) — Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year.i More than two million patients worldwide undergo open heart surgery annuallyii, with most procedures requiring a sternotomy, an approach that involves splitting the breastbone to open the chest and access the heart. “Opening...

Geneva, Switzerland, Jan. 26, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a global leader in semiconductors, PKI, and post-quantum cryptography (PQC) hardware and software solutions, today announced a live demonstration exploring its Post-Quantum Cryptography Robotic Concept during the Physical AI Roundtable held in Davos on the margins of the World Economic Forum Annual Meeting. The demonstration featured WISeRobot, developed in cooperation with its parent company WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, and illustrated the potential and need for post-quantum security to one day be embedded directly into physical AI and robotic systems. As quantum computing continues to advance, many of today’s cryptographic...

WARWICK, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSCD), a provider of innovative energy solutions and strategic growth platforms, today highlighted the leadership behind Varon Corp, led by its Founder and Chief Executive Officer, Benjamin Varon Schubert. Mr. Varon Schubert brings a proven track record of disciplined execution, brand development, and operational leadership across the fashion, licensing, and lifestyle sectors. Over the course of his career, he has been directly involved in the creation, commercialization, and long-term management of licensing and brand partnerships associated with globally recognized cultural properties like the Rolling Stones and AC/DC as well as A-list international celebrities and global icons. These experiences provided early exposure to complex, multi-party commercial...

AB Akola Group, one of the largest agricultural and food production groups in the Baltics, through its subsidiary Vilniaus Paukštynas, is considering the implementation of an investment project in Kaišiadorys related to the development of infrastructure for the processing of animal by-products. The total value of the planned investment could reach EUR 34 million. In the near future, the company plans to submit an application to the National Paying Agency and to participate in the upcoming European Union funding call in order to seek financial support. Final decisions regarding the investment will be made after assessing the funding conditions and obtaining all required permits and approvals. “This investment is an important part of the long-term development of our poultry business. It would enable more efficient handling of animal by-products...

ANTIOCH, Tenn., Jan. 26, 2026 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) (“LKQ” or “the Company”) today announced that its Board of Directors has initiated a comprehensive review of strategic alternatives to enhance shareholder value. As part of the review, the Board is working with its advisors to evaluate the Company’s strategic alternatives, including a potential sale of the Company. “The Board and management continually evaluate the Company’s performance and strategic positioning as part of our responsibility to maximize shareholder returns,” said John Mendel, Chairman of the Board. “Consistent with this commitment, we have initiated a formal review of strategic alternatives to identify the best path forward to unlock value that is not reflected in our current valuation.” Separately, the Company is continuing with its...

As the brand marks four decades, the Spring collection honors Arhaus’ legacy of personal expression, timeless style, and artisan-crafted designBOSTON HEIGHTS, Ohio, Jan. 26, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), today announced the launch of its Spring 2026 Collection, now available at Arhaus.com and in showrooms nationwide. Featuring hundreds of furniture and décor introductions, the collection reflects a renewed sense of creative expression, layering color, pattern, sculptural form, and natural materials into designs that feel both artful and deeply livable. Rooted in craft and elevated by design, the Spring 2026 Collection reflects Arhaus’ enduring belief that home is not just something you see, it’s something you feel. “This is Arhaus like you’ve never seen,” said Arhaus Co-Founder...